Engineers Gate Manager’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Buy
32,502
+12,303
+61% +$4.19M 0.13% 186
2025
Q4
$8.03M Sell
20,199
-23,650
-54% -$10.5M 0.1% 235
2025
Q3
$20M Buy
43,849
+11,219
+34% +$4.57M 0.23% 85
2025
Q2
$10.6M Buy
32,630
+7,238
+29% +$2M 0.13% 209
2025
Q1
$6.86M Sell
25,392
-8,505
-25% -$2.19M 0.12% 242
2024
Q4
$7.98M Buy
33,897
+22,034
+186% +$5.79M 0.14% 208
2024
Q3
$3.26M Buy
11,863
+4,789
+68% +$1.25M 0.06% 429
2024
Q2
$1.72M Sell
7,074
-17,649
-71% -$2.79M 0.04% 625
2024
Q1
$3.69M Buy
24,723
+7,292
+42% +$1.22M 0.1% 277
2023
Q4
$3.34M Buy
+17,431
New +$2.97M 0.1% 289
2023
Q3
Sell
-5,286
Closed -$1M 1769
2023
Q2
$1M Sell
5,286
-909
-15% -$180K 0.04% 689
2023
Q1
$1.24M Buy
+6,195
New +$1.3M 0.05% 504
2022
Q4
Sell
-1,957
Closed -$392K 1652
2022
Q3
$392K Sell
1,957
-3,467
-64% -$661K 0.02% 958
2022
Q2
$791K Buy
+5,424
New +$769K 0.03% 848
2022
Q1
Sell
-1,990
Closed -$337K 1817
2021
Q4
$337K Buy
1,990
+856
+75% +$159K 0.02% 1320
2021
Q3
$214K Sell
1,134
-14,830
-93% -$2.78M 0.01% 1402
2021
Q2
$2.71M Buy
15,964
+13,054
+449% +$1.91M 0.17% 114
2021
Q1
$411K Buy
2,910
+420
+17% +$63.2K 0.02% 1114
2020
Q4
$324K Buy
2,490
+1,090
+78% +$146K 0.01% 1252
2020
Q3
$204K Sell
1,400
-2,100
-60% -$298K 0.01% 1425
2020
Q2
$518K Buy
+3,500
New +$472K 0.03% 926
2020
Q1
Sell
-3,260
Closed -$375K 1537
2019
Q4
$375K Buy
+3,260
New +$325K 0.02% 1137
2015
Q4
Sell
-4,600
Closed -$370K 637
2015
Q3
$370K Buy
4,600
+2,100
+84% +$233K 0.03% 492
2015
Q2
$300K Buy
+2,500
New +$299K 0.03% 795

Other funds holding ALNY